MedTrace Logo

Predictors, Risk Factors and Outcome Following Major Surgery

NCT02626546 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1061

Last updated 2021-09-22

No results posted yet for this study

Summary

This is a multicentre, prospective, observational cohort study. Consecutive patients, operated in six University Hospitals in Sweden will be recruited following major surgical procedure. The length of patient recruitment period will be 12 weeks. The length of follow up will be 360 days . The objectives are to determine the postoperative morbidity (during the hospital stay), the survival (0-360 days), to identify risk factors for adverse outcomes and to identify risk factors that may potentially be influenced by any intervention in the future.

Amendments:

1. The follow-up of mortality is extended to 3 years of the cohort
2. The mortality of the background population at 30 and 90 Days will be analyzed
3. Validation of the Surgical Outcome Risk Tool in the study cohort and in the background population are planned

Conditions

  • Surgical Procedure, Unspecified
  • Postoperative Complications

Interventions

PROCEDURE

Major surgical procedure

observation of postoperative outcomes

Sponsors & Collaborators

  • Norrlands University Hospital

    collaborator OTHER

  • Region Örebro County

    collaborator OTHER

  • University Hospital, Linkoeping

    collaborator OTHER

  • Uppsala University Hospital

    collaborator OTHER

  • Karolinska Institutet

    lead OTHER

Principal Investigators

  • Sigriduar Kalman, MD PhD · Karolinska Institutet

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2016-08-31
Completion
2020-09-30

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02626546 on ClinicalTrials.gov